Agreement signed for the production of Sputnik V in Italy

According to the news of the Italian Adnkronos agency based on the Italian-Russian Chamber of Commerce, the Swiss-based Adienne Pharma & Biotech company, which also has a branch in Italy with the Russian Direct Investment Fund (RDIF), has reached an agreement on vaccine production in Italy. It was noted that the agreement aims to start production in Italy in July and to provide 10 million doses of Sputnik V vaccine by the end of 2021.…

"Agreement signed for the production of Sputnik V in Italy"